Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6920
Peer-review started: June 30, 2023
First decision: July 28, 2023
Revised: August 9, 2023
Accepted: September 5, 2023
Article in press: September 5, 2023
Published online: October 6, 2023
Processing time: 86 Days and 23.1 Hours
Various treatment methods are available for the treatment of pancreatic arteriovenous malformation (P-AVM); however, there are no established treatment options for asymptomatic P-AVM.
A 47-year-old and a 50-year-old male patients sought treatment for P-AVM in the pancreas, which was incidentally detected during routine abdominal computed tomography and magnetic resonance imaging conducted as part of a health check-up. They underwent transcatheter arterial embolization (TAE), and over the course of a 9-year follow-up period, the AVM did not worsen and was asymp
TAE can be considered as an alternative treatment option for P-AVM in selective cases where patients are asymptomatic or have a high surgical risk.
Core Tip: Pancreatic arteriovenous malformation (P-AVM) is a rare condition characterized by symptoms like gastrointestinal bleeding and abdominal pain, with some cases being asymptomatic. Surgical intervention is commonly considered for symptomatic cases, but the treatment of asymptomatic P-AVMs is not well-established. Previous studies have reported various methods, including surgery and transcatheter arterial embolization (TAE). In selective cases, particularly for asymptomatic or high surgical risk patients, TAE may be an effective and safe treatment option.
